Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN

2 abstracts

Abstract
Phase 1 study to determine the safety and efficacy of onvansertib, a novel, oral, PLK1 inhibitor in patients with proliferative chronic myelomonocytic leukemia relapsed/refractory or intolerant to available therapies.
Org: Division of Hematology, Mayo Clinic, Rochester, MN, Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, Division of Hematopathology, Mayo Clinic, Rochester, MN,
Abstract
Alliance A022101: A pragmatic, randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur).
Org: Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, Northwell Health, New Hyde Park, NY, Medical College of Wisconsin, Milwaukee, WI, Mayo Clinic Arizona, Scottsdale, AZ,